PCN112 Cyclin Dependent Kinase (CDK) 4/6 Inhibitors and LUNG Inflammation: An Analysis of the United States FOOD and Drug Administrations' Adverse Event Reporting System
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.204
https://www.valueinhealthjournal.com/article/S1098-3015(21)00421-6/fulltext
Title :
PCN112 Cyclin Dependent Kinase (CDK) 4/6 Inhibitors and LUNG Inflammation: An Analysis of the United States FOOD and Drug Administrations' Adverse Event Reporting System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00421-6&doi=10.1016/j.jval.2021.04.204
First page :
Section Title :
Open access? :
No
Section Order :
10784